How should a patient with moderate-to-severe aortic stenosis presenting with chest pain be managed?

Management of Moderate-to-Severe Aortic Stenosis with Chest Pain

A patient with moderate-to-severe aortic stenosis presenting with chest pain requires immediate evaluation to distinguish between angina from AS-related subendocardial ischemia versus acute coronary syndrome, followed by prompt consideration for aortic valve replacement if symptoms are attributable to the stenosis. 1

Initial Diagnostic Approach

Determine if Chest Pain is AS-Related or ACS

The critical first step is distinguishing the etiology of chest pain:

• AS-related angina occurs from:

  • Increased myocardial oxygen demand from left ventricular hypertrophy
  • Reduced coronary perfusion pressure
  • Subendocardial ischemia even without coronary disease 2, 3

• Look for ACS mimics: Severe AS can present with troponin elevation and ECG changes that mimic acute coronary syndrome, creating diagnostic confusion 3

• Obtain coronary angiography if:

  • Troponin is elevated
  • ECG shows ischemic changes
  • Patient has cardiac risk factors
  • Age >40 years (men) or >50 years (women)

Critical caveat: Coronary physiological indices (FFR, iFR) are not validated in AS patients and can provide misleading results due to altered hemodynamics from the stenotic valve 2. Severe AS interferes with accurate assessment of intermediate coronary lesions.

Severity Confirmation

Verify stenosis severity with echocardiography:

• Severe AS criteria:

  • Peak velocity (Vmax) ≥4 m/sec OR
  • Mean gradient ≥40 mmHg OR
  • Aortic valve area (AVA) ≤1.0 cm² (or indexed AVA ≤0.6 cm²/m²)

• Moderate AS criteria:

  • Vmax 3.0-3.9 m/sec
  • Mean gradient 20-39 mmHg
  • AVA 1.0-1.5 cm²

4, 1

Treatment Algorithm

For Symptomatic Severe AS with Chest Pain:

Aortic valve replacement (AVR) is appropriate and should be pursued 1. The presence of chest pain qualifies as a symptom directly attributable to severe AS, making intervention a Class I indication.

Choice of intervention:

• Low surgical risk: Either SAVR or TAVR is appropriate
• Intermediate/High surgical risk: TAVR is appropriate 1
• Prohibitive surgical risk: TAVR is the only option

For Symptomatic Moderate AS with Chest Pain:

This represents a gray zone. If chest pain is clearly anginal and coronary disease is excluded, consider:

1. Medical management first with close surveillance (echo every 6-12 months) 5
2. Early AVR may be reasonable if:
   • LVEF is declining (approaching <50%)
   • Symptoms are progressive despite medical therapy
   • Evidence of LV dysfunction on advanced imaging 6, 7

Recent evidence suggests moderate AS carries higher morbidity and mortality than previously recognized 6, 7, but current guidelines do not provide Class I recommendations for intervention in moderate AS.

Concomitant Coronary Disease Management:

If significant CAD is identified:

• Severe AS + CAD requiring revascularization: Perform combined SAVR + CABG 1, 8
• Do not rely on FFR/iFR to guide PCI decisions pre-AVR—these indices are unreliable in AS 2
• Consider staged approach: AVR first, then reassess coronary lesions post-valve replacement, as hemodynamics normalize after valve intervention 2

Medical Management Pending Intervention

While awaiting AVR:

• Treat hypertension cautiously: Avoid excessive afterload reduction that could compromise coronary perfusion
• Beta-blockers: Use carefully; may worsen symptoms in severe AS
• Nitrates: Generally avoided in severe AS due to risk of hypotension
• Manage heart failure: Diuretics for volume overload, but avoid aggressive diuresis
• Antiplatelet therapy: If concurrent CAD

5

Critical Pitfalls to Avoid

1. Do not delay AVR in symptomatic severe AS while pursuing extensive coronary workup—the valve is the primary problem 1

2. Do not assume chest pain is purely coronary without confirming AS severity—subendocardial ischemia from AS alone can cause angina 2, 3

3. Do not use FFR/iFR to defer coronary intervention in AS patients—wait until post-AVR to reassess borderline lesions 2

4. Do not adopt "watchful waiting" once symptoms appear in severe AS—survival drops precipitously without intervention 5, 9

5. Do not dismiss moderate AS as benign if symptoms are present and progressive—these patients have worse outcomes than previously recognized 6, 7

Timing of Intervention

For severe AS with chest pain: Intervention should occur within weeks, not months. Symptomatic severe AS has a 50% mortality at 2 years without treatment 4, 5.

For moderate AS with chest pain: Serial imaging every 6-12 months with low threshold for intervention if progression to severe or if LVEF declines 6, 5.